• imageedit_3_4668272017
  • Create Own Patient Registry

  • ABOUT US

  • CONTACT US

  • More

    Use tab to navigate through the menu items.
    Login to access your registry
    FINAL LOGO_IBDENC.png
    Create Own Patient Registry

    The Mission

    Key Opinion Leaders

    International

    Advisory Board

    Initiatives

    Discuss a case

    Journal Scan

    Latest News

    Education Hub 

    Gallery

    IBDENC ENC
    • Feb 18

    Early discontinuation of biological therapy among inflammatory bowel disease patients in Bahrain

    Early discontinuation of biological therapy among inflammatory bowel disease patients in Bahrain: Real world experience Maheeba Abdulla, Jehad AlQamish, Nafeesa Mohammed, Mahmood Al Saeed, Hasan Jawad Al Aali, Aysha Al Khaja, Zahra Abdulla Isa Yusuf Hasan, Fatema Yusuf Haider, Sayed Dhiyaa Noor Ebrahim, Zahra Sayed Alawi Mahfoodh, Mahmood Ali Hasan Hubail, Isa Alhajri, Fatema Al-Matrook, Ahmed Tork Published in Jan 2022, Saudi Journal of gastroenterology. Abstract Background:
    0
    IBDENC ENC
    • Feb 17

    Immunomodulator withdrawal from anti-TNF therapy is not associated with loss of response in inflamma

    Immunomodulator withdrawal from anti-TNF therapy is not associated with loss of response in inflammatory bowel disease R. Mahmoud,J.P.D. Schultheiss,J.M. Louwers,M.T. van der Kaaij,B.P. van Hellemondt,N. Mahmmod,P.G. van Boeckel,B. Jharap,H.H. Fidder,B. Oldenburg Published in Clinical Gastroenterology and Hepatology. Background And Aims The benefit of concomitant immunomodulators (thiopurines or methotrexate) in patients with inflammatory bowel disease (IBD) on anti-tumor nec
    0
    IBDENC ENC
    • Feb 16

    Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection

    Prevalence of Gastrointestinal Symptoms in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Results of the Prospective Controlled Multinational GI-COVID-19 Study Giovanni Marasco, Cesare Cremon, Maria Raffaella Barbaro, Daniele Salvi, Giulia Cacciari, Anna Kagramanova, Dmitry Bordin, Vasile Drug, Edgidia Miftode, Pietro Fusaroli, Salem Youssef Mohamed, Chiara Ricci , Massimo Bellini, M Masudur Rahman, Luigi Melcarne, Javier Santos, Beatriz Lobo, Serhat Bor, Suna Yap
    0
    IBDENC ENC
    • Feb 16

    SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS

    SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE Muhammad Khan,Kamran Mushtaq,Muhammad Saddique,Mohd Alghizzawi,Muhammad Yasir,Hafiz Younis,Farah Rashid,Deema AlSoub,Rafie Yakoob,Saad AlKaabi,Khalid Al-Ejji Published in Gastroenterology, February 2022. Background & Aims The effectiveness of currently available SARS-CoV-2 vaccines in patients with inflammatory bowel disease (IBD) remains unknown.
    0
    IBDENC ENC
    • Feb 16

    Nutritional screening and assessment in inflammatory bowel disease

    Nutritional screening and assessment in inflammatory bowel disease Arshdeep Singh, Catherine Wall, Arie Levine, Vandana Midha, Ramit Mahajan, Ajit Sood Published in Jan 2022, Indian journal of gastroenterology. Abstract Inflammatory bowel disease (IBD) is associated with increased risk of malnutrition and sarcopenia. Both malnutrition and sarcopenia negatively impact the clinical course, quality of life, response to therapy, and surgical outcomes in patients with IBD. This r
    0
    IBDENC ENC
    • Feb 15

    Incidence, Prevalence, and Clinical Epidemiology of Inflammatory Bowel Disease in the Arab World

    Incidence, Prevalence, and Clinical Epidemiology of Inflammatory Bowel Disease in the Arab World: A Systematic Review and Meta-Analysis Mahmoud Mosli, Sameer Alawadhi, Fuad Hasan, Antoine Abou Rached, Faisal Sanai, Silvio Danese Published in Sept 2021, Inflammatory Intestinal Diseases. Abstract Objectives: Despite the recent findings of the rising incidence of inflammatory bowel disease (IBD) in Arab countries, there are limited data on the characteristics of IBD patients and
    0
    IBDENC ENC
    • Feb 15

    The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to

    The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial Yanai H, Levine A, Hirsch A, Boneh RS, Kopylov U, Eran HB, Cohen NA, Ron Y, Goren I, Leibovitzh H, Wardi J, Zittan E, Ziv-Baran T, Abramas L, Fliss-Isakov N, Raykhel B, Gik TP, Dotan I, Maharshak N. Published in Lancet Gastroenterol Hepatol. 2022 Jan. Abstract Background: The Crohn's disease exclusion
    0
    IBDENC ENC
    • Feb 15

    Accuracy of Gastrointestinal Ultrasound and Calprotectin in the Assessment of Inflammation

    Accuracy of Gastrointestinal Ultrasound and Calprotectin in the Assessment of Inflammation and its Location in Patients with an Ileoanal Pouch Zaid S Ardalan, Antony B Friedman, Danny Con, Sujievvan Chandran, David Gibson, Alan Pham, Peter De Cruz, Kwang Tay, Stephen Bell, Ourania Rosella, Miles P Sparrow, Peter R Gibson Published in Journal of Crohn's and Colitis. Abstract Background and Aims In symptomatic patients with ileoanal pouches, pouchoscopy is needed for accurate d
    0
    IBDENC ENC
    • Feb 15

    Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset IBD: Systematic Review

    Twenty-first Century Trends in the Global Epidemiology of Pediatric-Onset Inflammatory Bowel Disease: Systematic Review M. Ellen Kuenzig,Stephen G. Fung,Luba Marderfeld,Joyce W.Y. Mak,Gilaad G. Kaplan,Siew C. Ng,David C. Wilson,Fiona Cameron,Paul Henderson,Paulo G. Kotze,Jasmine Bhatti,Vixey Fang,Samantha Gerber,Evelyne Guay,Supun Kotteduwa Jayawarden,Leo Kadota,D. Fernando,Maldonado,Jessica Amankwah Osei,Ryan Sandarage,Amanda Stanton,Melissa Wan Published in Gastroenterology
    0
    IBDENC ENC
    • Feb 14

    Inflammatory bowel diseases in Tamil Nadu: A survey of demographics, clinical profile, and practices

    Inflammatory bowel diseases in Tamil Nadu: A survey of demographics, clinical profile, and practices Yewale RV, Natarajan K, Ubal Dhus J, Parameswaran SA, Ramaswamy Palaniswamy K, Babu Vinish D, Somasundaram A, Ramakrishnan A, Karmegam S, Arun RS, Manmohan US, Mahadevan B, Harri Prasad B, Chandrasekar TS, Gokul BJ, Dutta A, Joseph AJ, Venkatraman J, Ganesh P, Shanmuganathan S, Alagammai PL, Ramasubramanian R, Venkatakrishnan L, Ganesan R, Chandrasekaran Arun A, Srinivas S, Ka
    0
    IBDENC ENC
    • Feb 9

    Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic

    Effects of vitamin D supplementation on blood markers in ulcerative colitis patients: a systematic review and meta-analysis. Guan Y, Hao Y, Guan Y, Bu H, Wang H. Published in:Eur J Nutr. 2022 Feb. Abstract Objective: Observational studies have shown that vitamin D levels are inversely related to ulcerative colitis activity, yet evidence from population interventions remains inconsistent. We conducted a systematic review and meta-analysis of randomized-controlled trials to cla
    0
    IBDENC ENC
    • Feb 9

    Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for

    Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis Lukin D, Faleck D, Xu R, Zhang Y, Weiss A, Aniwan S, Kadire S, Tran G, Rahal M, Winters A, Chablaney S, Koliani-Pace JL, Meserve J, Campbell JP, Kochhar G, Bohm M, Varma S, Fischer M, Boland B, Singh S, Hirten R, Ungaro R, Lasch K, Shmidt E, Jairath V, Hudesman D, Chang S, Swaminath A, Shen B, Kane S, Loftus EV Jr, Sands BE, Colombel JF, Siegel CA, Sandborn W
    0
    1
    2
    HOME
    CONTACT US
    GET INVOLVED
    FINAL LOGO_IBDENC.png
    Designed by nuvoteQ